WASHINGTON—The FCC conducted its monthly open virtual meeting on Wednesday, Sept. 30, during which they voted on new time frames for a couple broadcast regulations…
Reven Selects APCER Life Sciences as Its Service Provider in Pharmacovigilance, Safety Monitoring, Quality Assurance and Regulatory Affairs for Its Upcoming COVID-19 Clinical Trial
GOLDEN, Colo.–(BUSINESS WIRE)–Reven Holdings, Inc. (“Reven”) is a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment…